A Quick Look at Today's Ratings for Exact Sciences(EXAS.US), With a Forecast Between $75 to $84
On Sep 17, major Wall Street analysts update their ratings for $Exact Sciences(EXAS.US)$, with price targets ranging from $75 to $84.Citi analyst Patrick B Donnelly maintains with a buy rating, and
The Battle Brewing Over Blood Tests for Cancer -- Heard on the Street -- WSJ
Express News | Exact Sciences Corp : Btig Raises Target Price to $82 From $70
Buy Rating Affirmed for Exact Sciences on Robust CRC Test Results and Strategic Pipeline Advancements
Exact Sciences' New Test Positively Identifies More Than 88% of Cases of Colorectal Cancer, Company Says
ESMO 2024: Exact Sciences Unveils Results From Cancer Algorithm Trial